Published in J Thorac Oncol on February 01, 2012
Intravitreal bevacizumab in the successful management of choroidal metastases secondary to lung and breast cancer unresponsive to systemic therapy: a case series. Eye (Lond) (2014) 1.09
Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy. Case Rep Ophthalmol Med (2015) 0.95
Intravitreal bevacizumab for consecutive multiple choroidal breast metastatic lesions. BMJ Case Rep (2012) 0.93
Alectinib for choroidal metastasis in a patient with crizotinib-resistant ALK rearranged positive non-small cell lung cancer. Onco Targets Ther (2015) 0.78
Treatment of choroid metastasis from lung adenocarcinoma with bevacizumab-containing chemotherapy: A case report. Exp Ther Med (2015) 0.75
Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. J Natl Cancer Inst (2008) 1.92
Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage (2004) 1.67
Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort. J Transl Med (2014) 1.59
Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases. N Z Med J (2003) 1.47
Endocrine side effects induced by immune checkpoint inhibitors. J Clin Endocrinol Metab (2013) 1.42
Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations. Eur J Hum Genet (2004) 1.29
Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis. Tumour Biol (2014) 1.29
Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma. Cancer Immunol Immunother (2014) 1.23
Physical exercise and quality of life in breast cancer survivors. Int J Med Sci (2008) 1.14
Fibroblast growth factor receptors, developmental corruption and malignant disease. Carcinogenesis (2013) 1.10
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases. J Neurooncol (2014) 1.09
Radiosensitization by oxaliplatin in a mouse adenocarcinoma: influence of treatment schedule. Int J Radiat Oncol Biol Phys (2002) 1.08
Long-term survival in metastatic pancreatic cancer. A case report and review of the literature. JOP (2006) 1.06
Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors. Cancer Res (2006) 1.06
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access program. Cancer Invest (2014) 1.06
The use of bevacizumab in non-small cell lung cancer: an update. Anticancer Res (2014) 1.06
Metronomic chemotherapy for cancer treatment: a decade of clinical studies. Cancer Chemother Pharmacol (2013) 1.03
Gastrointestinal stromal tumors: correlation between symptoms at presentation, tumor location and prognostic factors in 47 consecutive patients. World J Surg Oncol (2011) 0.99
Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol (2012) 0.97
Changes of topoisomerase IIalpha expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival. Clin Cancer Res (2006) 0.93
Dermoscopic patterns of cutaneous melanoma metastases. Melanoma Res (2004) 0.93
The Supportive Care Task Force at the University of L'Aquila: 2-years experience. Support Care Cancer (2005) 0.92
Chemotherapy for the biliary tract cancers: moving toward improved survival time. J Gastrointest Cancer (2012) 0.92
Effectiveness of liver metastasectomies in patients with metastatic colorectal cancer treated with FIr-B/FOx triplet chemotherapy plus bevacizumab. Clin Colorectal Cancer (2011) 0.91
The medical oncologist's role in palliative care: AIOM's position. Tumori (2010) 0.91
Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease. Oncol Rep (2002) 0.91
Contrast-enhanced computed tomographic colonography in the follow-up of colorectal cancer patients: a feasibility study. Eur Radiol (2002) 0.91
An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study. Clinicoecon Outcomes Res (2013) 0.91
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur J Endocrinol (2013) 0.90
Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism. J Med Chem (2008) 0.90
"Poker" association of weekly alternating 5-fluorouracil, irinotecan, bevacizumab and oxaliplatin (FIr-B/FOx) in first line treatment of metastatic colorectal cancer: a phase II study. BMC Cancer (2010) 0.90
Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme. J Exp Clin Cancer Res (2014) 0.89
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study. Breast Cancer Res Treat (2014) 0.88
Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy. World J Gastrointest Oncol (2012) 0.88
Premetastatic niche: ready for new therapeutic interventions? Expert Opin Ther Targets (2012) 0.87
Intradermal lymphoscintigraphy at rest and after exercise: a new technique for the functional assessment of the lymphatic system in patients with lymphoedema. Nucl Med Commun (2010) 0.87
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells. Bioorg Med Chem Lett (2007) 0.87
Use of interim [18F]fluorodeoxyglucose-positron emission tomography is not justified in diffuse large B-cell lymphoma during first-line immunochemotherapy. Leuk Lymphoma (2011) 0.86
Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. Bioorg Med Chem Lett (2006) 0.85
A liquid chromatography-tandem mass spectrometry method for the determination of 5-Fluorouracil degradation rate by intact peripheral blood mononuclear cells. Ther Drug Monit (2009) 0.85
Overcoming cultural barriers to giving bad news: feasibility of training to promote truth-telling to cancer patients. J Cancer Educ (2009) 0.85
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. Future Oncol (2013) 0.85
A systematic review of experimental and clinical acupuncture in chemotherapy-induced peripheral neuropathy. Evid Based Complement Alternat Med (2013) 0.84
Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC software. Eur J Hum Genet (2006) 0.84
Tumors of ampulla of Vater: A case series and review of chemotherapy options. World J Gastrointest Oncol (2012) 0.84
Predictors of existential and religious well-being among cancer patients. Support Care Cancer (2010) 0.84
Design, synthesis and biological evaluation of novel stilbene-based antitumor agents. Bioorg Med Chem (2008) 0.83
Acupuncture in the treatment of menopause-related symptoms in women taking tamoxifen. Tumori (2002) 0.82
Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation. Breast Cancer Res Treat (2003) 0.82
Treatment-related side effects and quality of life in cancer patients. Support Care Cancer (2012) 0.82
New mutations and protein variants of NBS1 are identified in cancer cell lines. Genes Chromosomes Cancer (2003) 0.81
P16 hypermethylation contributes to the characterization of gene inactivation profiles in primary gastric cancer. Oncol Rep (2002) 0.81
Differential denaturation of serum proteome reveals a significant amount of hidden information in complex mixtures of proteins. PLoS One (2013) 0.81
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review. Tumori (2012) 0.81
Left ventricular apical ballooning in mitral endocarditis. Int J Cardiol (2006) 0.81
Could left ventricular apical ballooning represent spontaneous myocardial infarction abortion? Int J Cardiol (2008) 0.80
Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma. Tumori (2010) 0.80
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). Cancer Chemother Pharmacol (2013) 0.80
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer. Ann N Y Acad Sci (2009) 0.80
Postoperative adjuvant chemoradiation in completely resected locally advanced gastric cancer. Int J Radiat Oncol Biol Phys (2002) 0.80
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families. Breast Cancer Res Treat (2006) 0.80
Development of water soluble derivatives of cis-3, 4', 5-trimethoxy-3'-aminostilbene for optimization and use in cancer therapy. Invest New Drugs (2008) 0.80
Novel 3,4-isoxazolediamides as potent inhibitors of chaperone heat shock protein 90. J Med Chem (2011) 0.79
Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings. Clin J Pain (2015) 0.79
Knowledge and attitudes of Italian medical oncology residents toward the approach and treatment of pain. J Pain Symptom Manage (2003) 0.79
The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anticancer Drugs (2016) 0.79
Efficacy of treatment with tetracyclines to prevent acneiform eruption secondary to cetuximab therapy. Arch Dermatol (2005) 0.79
Versatile synthesis of new cytotoxic agents structurally related to hemiasterlins. Bioorg Med Chem Lett (2010) 0.79
Recent advances for the treatment of pancreatic and biliary tract cancer after first-line treatment failure. Expert Rev Anticancer Ther (2015) 0.79
Color Doppler imaging of the ophthalmic artery during antegrade selective cerebral perfusion. Tex Heart Inst J (2007) 0.79
Is delayed chemotherapy-induced emesis well managed in oncological clinical practice? An observational study. Support Care Cancer (2003) 0.79
Clinical classification of BRCA1 DNA missense variants: H1686Q is a novel pathogenic mutation occurring in the ontogenetically invariant THV motif of the N-terminal BRCT domain. J Clin Oncol (2008) 0.79
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. Chem Biol Interact (2009) 0.79
Genomic and epigenomic alterations in prostate cancer. Front Endocrinol (Lausanne) (2012) 0.79
Adjuvant endocrine therapy for perimenopausal women with early breast cancer. Breast (2008) 0.79
Differential gene expression profile of first-generation and second-generation rapamycin-resistant allogeneic T cells. Cytotherapy (2013) 0.78
Histologic and genetic advances in refining the diagnosis of "undifferentiated pleomorphic sarcoma". Cancers (Basel) (2013) 0.78
Prevalence of BRCA1 and BRCA2 genomic rearrangements in a cohort of consecutive Italian breast and/or ovarian cancer families. Breast Cancer Res Treat (2007) 0.78
Early hemodynamic results of the Shelhigh SuperStentless aortic bioprostheses. J Card Surg (2007) 0.78
Continuous, low-dose capecitabine for patients with recurrent colorectal cancer. Med Oncol (2015) 0.78
Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor. Invest New Drugs (2011) 0.78
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. BMC Cancer (2012) 0.77
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter study. Tumori (2015) 0.77
Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice. Future Oncol (2012) 0.77
A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer. BMC Cancer (2006) 0.77
Predictors of mood disorders in cancer patients' caregivers. Support Care Cancer (2012) 0.76
Natural medicine: a 'new frontier' in oncology? Ann Oncol (2005) 0.76
Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitors. Int J Cardiol (2013) 0.76
Duodenobronchial fistula arising from a necrotizing liver metastasis of right colon cancer after systemic chemotherapy. Am Surg (2010) 0.76
Fractionated stereotactic radiosurgery for patients with skull base metastases from systemic cancer involving the anterior visual pathway. Radiat Oncol (2014) 0.76
A metronomic schedule as salvage chemotherapy for upper gastrointestinal tract cancer. Anticancer Drugs (2016) 0.76
Pain evaluation and management: a survey of Italian radiotherapists. Support Care Cancer (2004) 0.75
Topical morphine in the treatment of painful ulcers. J Pain Symptom Manage (2005) 0.75
[Pharmacogenomics and chemotherapy]. Recenti Prog Med (2010) 0.75
Patient perception of disease control and psychological distress. Cancer Manag Res (2012) 0.75
Palliative care in advanced cancer patients: waiting for Godot. Oncologist (2012) 0.75